JAK inhibitors in rheumatoid arthritis
This will be a systematic review and meta-analysis of the use of JAK inhibitors for rheumatoid arthritis, and their cardiovascular complications. There is a prespecified sub-analysis for those aged over 65 years of aged
Publication Details
- Journal
- Open Science Framework
- Published
- 2025-01-01
- DOI
- https://doi.org/10.17605/osf.io/q7zwg
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00